Pulsar Helium Inc.

Share Issue/Capital Change • Dec 19, 2025

National Storage Mechanism | Additional information

RNS Number : 2019M

Pulsar Helium Inc.

19 December 2025

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS.

Unless otherwise defined herein, capitalized terms used in this announcement have the same meanings given to them in the Company's announcement dated November 4, 2025.

NEWS RELEASE |DECEMBER 19, 2025 | CASCAIS, PORTUGAL

PULSAR HELIUM CLOSES MAJOR MINNESOTA LAND POSITION TO THE WEST OF TOPAZ PROJECT AND TVR

Pulsar Helium Inc. (AIM: PLSR, TSXV: PLSR, OTCQB: PSRHF) ("Pulsar" or the "Company"), a primary helium exploration and development company, provides an update following its announcement on November 4, 2025, announcing the execution of a definitive agreement (the "Agreement") with Oscillate PLC ("Oscillate"), to acquire up to 100% of Oscillate's wholly owned subsidiary, Quantum Hydrogen Inc. in an all-share transaction (the "Transaction").

On December 18, 2025, the Company issued a total of 292,560 shares (the "Consideration Shares") to Oscillate satisfying the first and second monthly tranches of US$80,000 each, at a VWAP of C$0.7797 for tranche one and C$0.7543 for tranche two, pursuant to the terms of the Agreement, having received final acceptance from the TSXV. The remaining tranches, totaling US$640,000, will be satisfied over the coming months.

The Consideration Shares issued in connection with the Transaction are subject to a four-month-and-one-day hold period from the date of issuance.

Admission to AIM and Total Voting Rights

Application is being made to the London Stock Exchange plc for the admission of the 292,560 Common Shares issued pursuant to abovementioned Agreement, to be admitted to trading on AIM, which is expected to occur, and dealings commence at 8:00 a.m. on or around December 23, 2025. The new Common Shares will rank pari passu with the Company's existing Common Shares.

On Admission, the total number of Common Shares in issue will be 167,744,915 with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company's issued share capital pursuant to the Company's Articles.

On behalf Pulsar Helium Inc.

"Thomas Abraham-James"

President, CEO and Director

Further Information:

Pulsar Helium Inc.

[email protected]    

+ 1 (218) 203-5301 (USA/Canada)

+44 (0) 2033 55 9889 (United Kingdom)

https://pulsarhelium.com

https://ca.linkedin.com/company/pulsar-helium-inc.  

Strand Hanson Limited

(Nominated & Financial Adviser, and Broker)

Ritchie Balmer / Rob Patrick / Richard Johnson

+44 (0) 207 409 3494

Yellow Jersey PR Limited

(Financial PR)

Charles Goodwin / Annabelle Wills

+44 777 5194 357

[email protected]

About Pulsar Helium Inc.

Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of the London Stock Exchange and listed on the TSX Venture Exchange with the ticker PLSR, as well as on the OTCQB with the ticker PSRHF. Pulsar's portfolio consists of its flagship Topaz helium project in Minnesota, USA, and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCPKFBDCBDDCBD